Tumor progression and serum anti-HuD antibody concentration in patients with paraneoplastic neurological syndromes

European Neurology

Volumn 47, Issue 4, 2002, Pages 189-195

  Rauer, Sebastian ^a   Andreou, Ioanna ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anti Hu antibody concentration; Paraneoplastic anti Hu syndrome; Tumor prognosis

Indexed keywords

DNA BINDING PROTEIN; PROTEIN ANTIBODY; PROTIEN HUD; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; STANDARDIZATION; TUMOR GROWTH;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RETROSPECTIVE STUDIES; RNA-BINDING PROTEINS;

EID: 0036284258     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057897     Document Type: Article

References (22)

1. Paraneoplastic encephalomyelitis: An update of the effects of the anti-Hu immune response on the nervous system and tumour
2. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy
3. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal
4. Hu antigens: Reactivity with Hu antibodies, tumor expression, and major immunogenic sites
5. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor
6. Anti-Hu antibodies in patients with small-cell lung cancer: Association with complete response to therapy and improved survival
7. Demonstration of anti-HuD specific oligoclonal bands in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes - Qualitative evidence of anti-HuD specific IgG-synthesis in the central nervous system
8. Enzyme linked immunosorbent assay using recombinant HuD-autoantigen for serodiagnosis of paraneoplastic neurological syndromes
9. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients
10. Anti-Hu-associated paraneoplastic encephalomyelitis: Analysis of 200 patients
11. Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: Possible correlation of antibody concentration and course of neurological symptoms
12. Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer
13. Pitfalls in the diagnosis of autoan-tibodies associated with paraneoplastic neurologic disease
14. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: Report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, The Netherlands
15. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): The case for a nomenclature based on antibody and antigen specificity
16. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies
17. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer
18. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - A quantitative Western blot analysis
19. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: A distinct paraneoplastic syndrome
20. Paraneoplastic syndromes
21. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice
22. Therapeutic advances in small cell lung cancer